Developer docs
API playgroundTry for free, no card

Search company profiles

Propath

Full company profile

uuid000czi3

Namestring
Propath
Legal namestring
Propath UK Limited
Websiteurl
propath.co.uk
Company typeenum
Private
Founded yearint
1984
Descriptiontext

Propath UK Limited is a specialist contract research organization (CRO) focused on molecular pathology and histopathology services for biopharmaceutical research and development. The company operates from a 12,000 sq ft GLP- and GCP-compliant facility in Hereford, UK, with HTA licensing for human tissue handling. Propath is described as one of the largest GLP/GCP compliant contract pathology laboratories in Europe, with over 40 years of operating history and thousands of completed studies.

The company's service portfolio is anchored in spatial biology, with validated capability across multiple complementary platforms: NanoString GeoMx DSP for whole-transcriptome spatial profiling, NanoString CosMx for single-cell subcellular resolution, NanoString nCounter for bulk gene expression, Lunaphore COMET for hyper-plex sequential immunofluorescence, Akoya PhenoCycler/PhenoImager for high-plex phenotyping, and 10x Xenium for targeted spatial transcriptomics. These are supported by GLP/GCP-compliant histopathology services (tissue processing, special stains, IHC), molecular pathology (RNAscope ISH, proximity ligation assays), digital slide scanning, and cross-platform spatial bioinformatics. Propath is an accredited NanoString Core Lab and was among the first CROs globally to offer CosMx commercially.

Propath generates revenue through managed contract research services on a quote-based, project-by-project model, with pricing dependent on assay type, sample volume, panel complexity, turnaround time, and regulatory compliance requirements. Its go-to-market is consultative, enterprise field sales oriented, targeting biopharma study directors and sponsors directly, with secondary reach into biotech firms and academic medical centers. The customer base includes six of the world's top ten pharmaceutical companies, served through long-term relationships built on regulatory quality and domain specialization rather than broad service breadth.

Short descriptiontext

Propath is a UK-based specialist CRO offering GLP/GCP-compliant molecular pathology, histopathology, and spatial biology services (GeoMx, CosMx, COMET, Xenium) to biopharmaceutical R&D clients globally, including six of the top ten pharma companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHereford, United Kingdom
HQ citystring
Hereford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spatial biology services, molecular pathology CRO, histopathology contract research, biopharmaceutical research services, spatial transcriptomics CRO
Industry1 code
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) / Spatial Biology Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services (CRO)
TypeManaged Services
Description

Propath operates as a specialist CRO providing molecular pathology, spatial biology, and histopathology services on a contract basis for biopharmaceutical R&D. Services range from sample preparation through to data analysis, with pricing based on project scope, complexity, and turnaround requirements. Full managed service from study design to final reporting.

propath.co.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Propath is a specialist Contract Research Organization providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical drug discovery and development. The company operates multiple advanced platforms (NanoString GeoMx, CosMx, nCounter, Lunaphore COMET, Akoya PhenoCycler/PhenoImager, 10x Xenium) from a GLP/GCP compliant facility in Hereford, UK, delivering full managed-service engagements from study design through sample preparation, assay execution, and spatial bioinformatics data analysis for pharmaceutical and biotech sponsors worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Trusted by six of the world's top ten pharmaceutical companies
+3 more records
Product overview1 text field

Propath is a specialist Contract Research Organization (CRO) providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical R&D. The company operates as a service provider rather than a software product company, offering a integrated portfolio of spatial biology platforms and laboratory services. Core spatial biology platforms include NanoString GeoMx DSP for spatial transcriptomics/proteomics (up to 18,000 RNA targets), NanoString CosMx for single-cell subcellular resolution analysis, Lunaphore COMET for hyper-plex immunofluorescence (up to 40 markers), Akoya PhenoCycler/PhenoImager for high-plex spatial phenotyping, and 10x Xenium for targeted spatial transcriptomics. Molecular pathology services encompass RNAscope ISH, GLP/GCP compliant IHC, and multiplex method development. Histopathology services include GLP/GCP compliant histology, digital slide scanning, and expert pathology reviews. Spatial bioinformatics services provide cross-platform image analysis and data integration. All services are supported by NanoString nCounter for bulk gene expression analysis. Propath is accredited as a NanoString Core Lab, holds GLP/GCP compliance, and HTA licensing, with over 40 years of experience serving biopharma clients globally including six of the world's top ten pharmaceutical companies.

Product and service1 record
1NanoString GeoMx Digital Spatial Profiling Service
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-01-01
Description

Propath is an accredited NanoString Core Lab and established partner offering GeoMx DSP, CosMx, and nCounter services. Partnership enables comprehensive spatial multiomics services including whole transcriptome profiling and Cancer Transcriptome Atlas assays. Propath was among the first CROs globally to offer CosMx single-cell spatial analysis commercially.

Strategic tierSecondaryTypeTechnology or IntegrationAnnounced on2023-01-01
Description

Propath worked with Visiopharm and NanoString to develop AI-driven ROI/AOI selection for GeoMx DSP analysis, presented at SITC 2023. Collaboration enables automated detection of tumor subtypes based on hypoxia and immune infiltrate criteria using Oncotopix Discovery for unbiased, reproducible workflow.

Strategic tierSecondaryTypeTechnology or IntegrationAnnounced on2020-01-01
Description

Propath partnered with NanoString to launch a grant programme for researchers exploring COVID-19 pathogenesis and host response, enabling analysis of up to 24 RNA samples using NanoString panels with additional COVID-19 targets including the specific COVID-19 Panel Plus product.

Strategic tierCoreTypeTechnology or Integration
Description

Propath partnered with Lunaphore to offer hyper-plex immunofluorescence staining using the Lunaphore Comet instrument from their UK facility. The partnership enables fully automated sequential immunofluorescence (seqIF) staining and imaging for robust multiplex analysis of up to 40 different spatial markers per tissue slide, with applications across immuno-oncology, neuroscience, and infectious diseases.

Strategic tierCoreTypeTechnology or Integration
Description

Propath partnered with NanoString to bring the GeoMx Cancer Transcriptome Atlas to Europe, offering turn-key service for spatial profiling of 1,800 genes on clinical or experimental samples. The assay profiles tumor biology, microenvironment, and immune response with spatial resolution from a single tissue section.

Strategic tierSecondaryTypeTechnology or Integration
Description

Propath launched a grant programme for researchers developing ADC therapeutics using NanoString's nCounter ADC panel, enabling researchers to road-test the new panel measuring six distinct stages of ADC delivery and response in a single gene expression panel.

Strategic tierSecondaryTypeTechnology or Integration
Description

Propath offers Automated Proximity Ligation Assays by Navinci, enabling high-throughput, reproducible detection of protein-protein interactions and post-translational modifications in tissue for biopharma applications using automated PLA assays.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Targos is a German-based specialist clinical biomarker and pathology CRO supporting pharma clinical trials, with comparable GLP/GCP-compliant immunohistochemistry and molecular pathology offerings akin to Propath's regulated services.

TypeDirect peer
Description

Flagship Biosciences is a tissue-based CRO providing IHC, image analysis, and pathology services to biopharma, closely overlapping with Propath's histopathology and quantitative image analysis offerings.

TypeDirect peer
Description

HistoWiz is a digital pathology and histology CRO serving academic and biopharma clients with IHC, ISH, and slide scanning services, comparable to Propath's histopathology and digital slide scanning capabilities.

TypeDirect peer
Description

Mosaic Laboratories (part of Labcorp) provides GLP-compliant IHC, multiplex immunohistochemistry, and biomarker assay development for biopharma, mirroring Propath's regulated GLP/GCP-compliant IHC and multiplex method development.

TypeBroad incumbent
Description

Cell Signaling Technology is a broader life-science reagents company with an antibody and IHC services portfolio used by biopharma, representing a larger incumbent with overlapping capabilities to Propath's molecular pathology services.

TypeBroad incumbent
Description

NeoGenomics is a major clinical and biopharma pathology services provider offering IHC, FISH, and molecular testing at scale, a broader incumbent competing with Propath in regulated biomarker work for clinical trials.

TypeBroad incumbent
Description

Labcorp Drug Development (formerly Covance) is a full-service CRO offering central lab and biomarker/IHC services to biopharma, representing a broad incumbent overlapping with Propath's regulated central pathology and biomarker work.

TypeOthers
Description

Bio-Techne's ACD Bio division manufactures RNAscope ISH probes and runs associated services; Propath offers RNAscope as a GCP service, making ACD both a technology supplier and partial services competitor.

TypeOthers
Description

Indica Labs provides digital pathology image-analysis software (HALO) widely used for multiplex IHC and spatial biology workflows, an enabling technology provider adjacent to Propath's spatial bioinformatics services.

TypeEmerging player
Description

Active Motif offers epigenetics and genomic assay services (e.g., ATAC-Seq, ChIP-Seq) for biopharma, an emerging services player in adjacent molecular biology workflows that may be referenced by the same translational research clients as Propath.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Propath

Contract Research Organization (CRO) / Spatial Biology Servicespropath.co.uk

Propath is a UK-based specialist CRO offering GLP/GCP-compliant molecular pathology, histopathology, and spatial biology services (GeoMx, CosMx, COMET, Xenium) to biopharmaceutical R&D clients globally, including six of the top ten pharma companies.

What Propath does

Propath UK Limited is a specialist contract research organization (CRO) focused on molecular pathology and histopathology services for biopharmaceutical research and development. The company operates from a 12,000 sq ft GLP- and GCP-compliant facility in Hereford, UK, with HTA licensing for human tissue handling. Propath is described as one of the largest GLP/GCP compliant contract pathology laboratories in Europe, with over 40 years of operating history and thousands of completed studies.

The company's service portfolio is anchored in spatial biology, with validated capability across multiple complementary platforms: NanoString GeoMx DSP for whole-transcriptome spatial profiling, NanoString CosMx for single-cell subcellular resolution, NanoString nCounter for bulk gene expression, Lunaphore COMET for hyper-plex sequential immunofluorescence, Akoya PhenoCycler/PhenoImager for high-plex phenotyping, and 10x Xenium for targeted spatial transcriptomics. These are supported by GLP/GCP-compliant histopathology services (tissue processing, special stains, IHC), molecular pathology (RNAscope ISH, proximity ligation assays), digital slide scanning, and cross-platform spatial bioinformatics. Propath is an accredited NanoString Core Lab and was among the first CROs globally to offer CosMx commercially.

Propath generates revenue through managed contract research services on a quote-based, project-by-project model, with pricing dependent on assay type, sample volume, panel complexity, turnaround time, and regulatory compliance requirements. Its go-to-market is consultative, enterprise field sales oriented, targeting biopharma study directors and sponsors directly, with secondary reach into biotech firms and academic medical centers. The customer base includes six of the world's top ten pharmaceutical companies, served through long-term relationships built on regulatory quality and domain specialization rather than broad service breadth.

Propath firmographics

Firmographics
Name
Propath
Legal name
Propath UK Limited
Website
https://propath.co.uk
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
11–50 employees
Short description
Propath is a UK-based specialist CRO offering GLP/GCP-compliant molecular pathology, histopathology, and spatial biology services (GeoMx, CosMx, COMET, Xenium) to biopharmaceutical R&D clients globally, including six of the top ten pharma companies.
Ownership category
akta.pro rank

Propath industry classification

Industry
Product category
Contract Research Organization (CRO) / Spatial Biology Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Spatial biology services
  • Molecular pathology CRO
  • Histopathology contract research
  • Biopharmaceutical research services
  • Spatial transcriptomics CRO

Where Propath is headquartered

Location

Headquarters

HQ city
Hereford
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Propath business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Contract Research Services (CRO): Propath operates as a specialist CRO providing molecular pathology, spatial biology, and histopathology services on a contract basis for biopharmaceutical R&D. Services range from sample preparation through to data analysis, with pricing based on project scope, complexity, and turnaround requirements. Full managed service from study design to final reporting.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Propath product offering

Product offering

Core offering

Propath is a specialist Contract Research Organization providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical drug discovery and development. The company operates multiple advanced platforms (NanoString GeoMx, CosMx, nCounter, Lunaphore COMET, Akoya PhenoCycler/PhenoImager, 10x Xenium) from a GLP/GCP compliant facility in Hereford, UK, delivering full managed-service engagements from study design through sample preparation, assay execution, and spatial bioinformatics data analysis for pharmaceutical and biotech sponsors worldwide.

Product overview

Propath is a specialist Contract Research Organization (CRO) providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical R&D. The company operates as a service provider rather than a software product company, offering a integrated portfolio of spatial biology platforms and laboratory services. Core spatial biology platforms include NanoString GeoMx DSP for spatial transcriptomics/proteomics (up to 18,000 RNA targets), NanoString CosMx for single-cell subcellular resolution analysis, Lunaphore COMET for hyper-plex immunofluorescence (up to 40 markers), Akoya PhenoCycler/PhenoImager for high-plex spatial phenotyping, and 10x Xenium for targeted spatial transcriptomics. Molecular pathology services encompass RNAscope ISH, GLP/GCP compliant IHC, and multiplex method development. Histopathology services include GLP/GCP compliant histology, digital slide scanning, and expert pathology reviews. Spatial bioinformatics services provide cross-platform image analysis and data integration. All services are supported by NanoString nCounter for bulk gene expression analysis. Propath is accredited as a NanoString Core Lab, holds GLP/GCP compliance, and HTA licensing, with over 40 years of experience serving biopharma clients globally including six of the world's top ten pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • NanoString GeoMx Digital Spatial Profiling Service

Quantifiable outcome

  • Trusted by six of the world's top ten pharmaceutical companies
  • +3 more outcomes

Companies that use Propath

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Propath technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Propath partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and secondary.

  • NanoStringcoreTechnology or Integration · 1 January 2023Propath is an accredited NanoString Core Lab and established partner offering GeoMx DSP, CosMx, and nCounter services. Partnership enables comprehensive spatial multiomics services including whole transcriptome profiling and Cancer Transcriptome Atlas assays. Propath was among the first CROs globally to offer CosMx single-cell spatial analysis commercially.
  • VisiopharmsecondaryTechnology or Integration · 1 January 2023Propath worked with Visiopharm and NanoString to develop AI-driven ROI/AOI selection for GeoMx DSP analysis, presented at SITC 2023. Collaboration enables automated detection of tumor subtypes based on hypoxia and immune infiltrate criteria using Oncotopix Discovery for unbiased, reproducible workflow.
  • NanoStringsecondaryTechnology or Integration · 1 January 2020Propath partnered with NanoString to launch a grant programme for researchers exploring COVID-19 pathogenesis and host response, enabling analysis of up to 24 RNA samples using NanoString panels with additional COVID-19 targets including the specific COVID-19 Panel Plus product.
  • LunaphorecoreTechnology or IntegrationPropath partnered with Lunaphore to offer hyper-plex immunofluorescence staining using the Lunaphore Comet instrument from their UK facility. The partnership enables fully automated sequential immunofluorescence (seqIF) staining and imaging for robust multiplex analysis of up to 40 different spatial markers per tissue slide, with applications across immuno-oncology, neuroscience, and infectious diseases.
  • NanoStringcoreTechnology or IntegrationPropath partnered with NanoString to bring the GeoMx Cancer Transcriptome Atlas to Europe, offering turn-key service for spatial profiling of 1,800 genes on clinical or experimental samples. The assay profiles tumor biology, microenvironment, and immune response with spatial resolution from a single tissue section.
  • NanoStringsecondaryTechnology or IntegrationPropath launched a grant programme for researchers developing ADC therapeutics using NanoString's nCounter ADC panel, enabling researchers to road-test the new panel measuring six distinct stages of ADC delivery and response in a single gene expression panel.
  • NavincisecondaryTechnology or IntegrationPropath offers Automated Proximity Ligation Assays by Navinci, enabling high-throughput, reproducible detection of protein-protein interactions and post-translational modifications in tissue for biopharma applications using automated PLA assays.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Propath competitors and assessment

Company assessment

Direct peers

  • Targos: Targos is a German-based specialist clinical biomarker and pathology CRO supporting pharma clinical trials, with comparable GLP/GCP-compliant immunohistochemistry and molecular pathology offerings akin to Propath's regulated services.
  • Flagship Biosciences: Flagship Biosciences is a tissue-based CRO providing IHC, image analysis, and pathology services to biopharma, closely overlapping with Propath's histopathology and quantitative image analysis offerings.
  • HistoWiz: HistoWiz is a digital pathology and histology CRO serving academic and biopharma clients with IHC, ISH, and slide scanning services, comparable to Propath's histopathology and digital slide scanning capabilities.
  • Mosaic Laboratories: Mosaic Laboratories (part of Labcorp) provides GLP-compliant IHC, multiplex immunohistochemistry, and biomarker assay development for biopharma, mirroring Propath's regulated GLP/GCP-compliant IHC and multiplex method development.

Broad incumbents

  • Cell Signaling Technology: Cell Signaling Technology is a broader life-science reagents company with an antibody and IHC services portfolio used by biopharma, representing a larger incumbent with overlapping capabilities to Propath's molecular pathology services.
  • NeoGenomics: NeoGenomics is a major clinical and biopharma pathology services provider offering IHC, FISH, and molecular testing at scale, a broader incumbent competing with Propath in regulated biomarker work for clinical trials.
  • Labcorp Drug Development: Labcorp Drug Development (formerly Covance) is a full-service CRO offering central lab and biomarker/IHC services to biopharma, representing a broad incumbent overlapping with Propath's regulated central pathology and biomarker work.

Others

  • ACD Bio / Bio-Techne (RNAscope): Bio-Techne's ACD Bio division manufactures RNAscope ISH probes and runs associated services; Propath offers RNAscope as a GCP service, making ACD both a technology supplier and partial services competitor.
  • Indica Labs: Indica Labs provides digital pathology image-analysis software (HALO) widely used for multiplex IHC and spatial biology workflows, an enabling technology provider adjacent to Propath's spatial bioinformatics services.

Emerging players

  • Active Motif: Active Motif offers epigenetics and genomic assay services (e.g., ATAC-Seq, ChIP-Seq) for biopharma, an emerging services player in adjacent molecular biology workflows that may be referenced by the same translational research clients as Propath.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Propath compliance and trust

Trust signal

Compliance3 records

Propath financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Propath leadership team

Management profile

Number of profiles

Profiles3 records

Propath funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Propath M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Propath

What does Propath do?

Propath is a specialist Contract Research Organization providing spatial biology, molecular pathology, and histopathology services for biopharmaceutical drug discovery and development. The company operates multiple advanced platforms (NanoString GeoMx, CosMx, nCounter, Lunaphore COMET, Akoya PhenoCycler/PhenoImager, 10x Xenium) from a GLP/GCP compliant facility in Hereford, UK, delivering full managed-service engagements from study design through sample preparation, assay execution, and spatial bioinformatics data analysis for pharmaceutical and biotech sponsors worldwide.

Is Propath a public or private company?

Propath is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Propath founded?

Propath was founded in 1984. It employs 11 to 50 people.

Where is Propath based?

Propath is headquartered in Hereford, United Kingdom, in the Europe region.

How does Propath make money?

One revenue line is on record: contract Research Services (CRO).

Who are Propath's main competitors?

Direct peers on record are Targos, Flagship Biosciences, HistoWiz and Mosaic Laboratories. Broad incumbents are Cell Signaling Technology, NeoGenomics and Labcorp Drug Development. Others are ACD Bio / Bio-Techne (RNAscope) and Indica Labs. Active Motif is listed as an emerging player.

Does Propath have an API?

No public API is recorded for Propath.

What industry is Propath in?

Propath's product category is Contract Research Organization (CRO) / Spatial Biology Services. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsRevolune Partners with Propath UK to Enhance Immunofluorescence Workflows for Biopharma ResearchRevolune announced a collaborative partnership with Propath UK, making Propath UK part of Revolune's Service Provider Program to expand access to Revolune's multiplex immunofluorescence workflow technology for biopharma research. The partnership enables customers to conduct assays internally or leverage Propath UK's UK-based service laboratory for antibody optimization, multiplex panel development, imaging, bioinformatics, and GCP-compliant tissue biomarker analysis for clinical trials. The collaboration aims to help researchers transition from traditional workflows to flexible multiplex immunofluorescence approaches without building capabilities in-house.FinanzNachrichten.deEQS-News: Revolune und Propath UK bieten ihren Kunden aus der Biopharma-Branche servicegestützte Workflows für die Multiplex-Immunfluoreszenz anRevolune announced a partnership with Propath UK under which Propath UK joins Revolune's service provider program to expand customer access to Revolune's Multiplex Immunofluorescence workflow for the biopharma industry. Propath UK will support customers seeking experienced service laboratory access to Revolune's multiplex staining workflows, offering services including antibody optimization, panel development, tissue preparation, imaging, bioinformatics, and GCP-compliant biomarker analysis for clinical trials. The collaboration aims to help researchers and translational teams implement flexible multiplex immunofluorescence workflows, either by conducting assays in-house or through Propath UK's service delivery.PR NewswireRevolune and Propath UK Bring Service-Backed Multiplex immunofluorescence Workflows to Biopharma CustomersRevolune announced a partnership with Propath UK to expand access to its multiplex immunofluorescence workflows through a service provider program. Propath UK will support customers with antibody optimization, panel development, imaging, and GCP-compliant biomarker analysis. The collaboration aims to help researchers adopt flexible workflows without building internal capabilities.Stock TitanNanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma ResearchersNanoString announced new partnerships with Macrogen, Propath UK, and Sirona Dx to offer CosMx Spatial Molecular Imager technology. These CROs provide global biopharma customers access to spatial biology tools for drug development. The partnerships aim to expand availability of NanoString's spatial imaging platforms.Business Wire BlogNanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma ResearchersNanoString announced new partnerships with Macrogen, Propath UK, and Sirona Dx to offer CosMx Spatial Molecular Imager to biopharma customers. The CROs provide access to the spatial biology tool, with Sirona Dx having acquired multiple systems and Propath UK being the first European CRO to offer a fully managed, GCP-compliant service.